According to Infomed (Cuba´s Health Network), the US newspaper registers 37 vaccines in human clinical trials and around 91 preclinical ones that are under active investigation in animals.
Updated on September 4 (for the last time), this interactive tool also includes general descriptions of different treatments and drugs to fight the SARS-CoV-2 coronavirus.
The Cuban vaccine candidate remains top priorities of the Cuban scientific community, which constantly assesses the results of its clinical trials.
Yury Valdes, deputy director of the Finlay Vaccine Institute, reported that after vaccinating the second 20-volunteer group in the trial, aged between 60 and 80 years, the candidate’s safety was verified by the country’s drug regulatory institution.
En el Centro Coordinador de Ensayo Clinico del @FinlayInstituto evaluamos que después de 40 sujetos vacunados #Soberana01 sigue en el camino de demostrar su seguridad. Todo bajo un alto estándar comprobado por el @cubacecmed durante 2 días de inspección. #CubaSalva pic.twitter.com/Vo3tXfKjqn
— Yury Valdés Balbín (@BalbinYury) September 4, 2020
On Twitter, Yury Valdes published that ‘after 40 vaccinated subjects, Soberana 01 continues on the path of proving its safety.’
Equipo de editores del sitio web de Radio Ciudad del Mar.